Literature DB >> 28900676

Free Fatty Acid Receptor 4 Mediates the Beneficial Effects of n-3 Fatty Acids on Body Composition in Mice.

Han Jin Cho1, Seong Hee Ahn2, Young-Sun Lee1, Seung Hun Lee3, Dong-Soon Im4, Inki Kim1,5, Jung-Min Koh3, Sungsub Kim6, Beom-Jun Kim7.   

Abstract

As populations continue to age worldwide, sarcopenic obesity has heightened interest due to its medical importance. Although much evidence now indicates that n-3 fatty acids (FAs) may have beneficial effects on body composition including fat and muscle, their exact mechanisms have not yet been elucidated. Because free FA receptor 4 (FFA4) has been reported to be a receptor for n-3 FAs, we hypothesized that the protective role of n-3 FAs on body composition could be mediated by FFA4. To test this possibility, we generated mice overexpressing n-3 FAs but lacking FFA4 by crossing fat-1 transgenic (fat-1 Tg+) and FFA4 knockout (Ffar4 -/-) mice. Because fat-1 Tg+ mice, in which n-6 is endogenously converted into n-3 FAs, contain high n-3 FA levels, they could be a good animal model for studying the effects of n-3 FAs in vivo. Male and female littermates were included in high-fat-diet- (HFD) and ovariectomy-induced models, respectively. In the HFD model, male fat-1 Tg+ mice had a lower percentage of fat mass and a higher percentage of lean mass than their wild-type littermates only when they had the Ffar4 +/+ not the Ffar4 -/- background. Female fat-1 Tg+ mice showed less increase of fat mass percentage and less decrease of lean mass percentage after ovariectomy than wild-type littermates. However, these effects on body composition were attenuated in the Ffar4 -/- background. Taken together, our results indicate that the beneficial effects of n-3 FAs on body composition were mediated by FFA4 and thus suggest that FFA4 may be a potential therapeutic target for modulating sarcopenic obesity.

Entities:  

Keywords:  Body composition; Fat-1; Free fatty acid receptor 4; Sarcopenic obesity; n-3 fatty acids

Mesh:

Substances:

Year:  2017        PMID: 28900676     DOI: 10.1007/s00223-017-0323-y

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  3 in total

Review 1.  Signaling through Free Fatty Acid Receptor 4 Attenuates Cardiometabolic Disease.

Authors:  Timothy D O'Connell; Katherine A Murphy; Naixin Zhang; Sara J Puccini; Chastity L Healy; Brian A Harsch; Michael J Zhang; Gregory C Shearer
Journal:  Physiology (Bethesda)       Date:  2022-08-09

2.  Free Fatty Acid Receptor 4 (FFA4) Activation Ameliorates Imiquimod-Induced Psoriasis in Mice.

Authors:  So-Eun Son; Jung-Min Koh; Dong-Soon Im
Journal:  Int J Mol Sci       Date:  2022-04-19       Impact factor: 6.208

3.  Lower Serum n-3 Fatty Acid Level in Older Adults with Sarcopenia.

Authors:  Il-Young Jang; Hee-Won Jung; Jin Hoon Park; Jeoung Hee Kim; Seungjoo Lee; Eunju Lee; Jin Young Lee; So Jeong Park; Da Ae Kim; Su Jung Kim; Hyun Ju Yoo; Beom-Jun Kim
Journal:  Nutrients       Date:  2020-09-27       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.